Literature DB >> 25878813

Crystal structure of 2,2'-oxybis(4-methylquinoline).

Anaelle Tilborg1.   

Abstract

The title compound, C20H16N2O, (I), has been unwittingly obtained from the slow evaporation of a saturated solution of commercial benserazide hydro-chloride [benserazide, (II), being one of the principal therapeutic compounds used for the management of Parkinson's disease, mostly used in combination with levodopa]. The mol-ecule of (I) is composed of two planar 4-methyl-quinoline aromatic moieties [maximum deviations of 0.0104 (18) and 0.016 (2) Å], almost perpendicular to each other [dihedral angle = 89.5 (2)°], bridged by an O atom. The supra-molecular organization consists of a π-bonded chain, resulting from the stacking of mol-ecules related by inversion centres located along direction [111].

Entities:  

Keywords:  Parkinson’s disease; benserazide; crystal structure; quinoline; therapeutic compounds

Year:  2015        PMID: 25878813      PMCID: PMC4384558          DOI: 10.1107/S2056989015000717

Source DB:  PubMed          Journal:  Acta Crystallogr E Crystallogr Commun


Chemical context

Parkinson’s disease is a degenerative disorder of the central nervous system, resulting from the death of dopamine-generating cells, mostly located in the mid-brain. The most obvious symptoms are movement-related: uncontrolled shaking, rigidity, slowness of movement and difficulty in walking. However, behavioral problems and psychiatric depression may also arise (Samii et al., 2004 ▸). Symptomatic treatment of Parkinson’s disease includes daily dopamine administration, principally through l-DOPA (or levodopa) or carbidopa (both being precursors of dopamine) brain metabolization. Benserazide [also called Serazide or Ro–4–4602, (II) in the Scheme] is an aromatic l-amino acid deca­rboxylase inhibitor and a DOPA deca­rboxylase inhibitor unable to cross the blood–brain barrier. It is used in combination with levodopa for the symptomatic management of Parkinson’s disease (Clark et al., 1973 ▸; Campanella & Pennetta, 1974 ▸; Bortolanza et al., 2015 ▸). As benserazide is always administered in combination therapy, it appeared to be a good candidate to search for a solid-state crystalline phase involving it with another thera­peutic mol­ecule, also active in the treatment of Parkinson’s disease. However, little information could be retrieved on the structural aspects of benserazide and, as a first step, recrystallization attempts of the mol­ecule alone have been launched. These crystallization assays have been so far fruitless, but resulted instead in the unwitting obtention of a new mol­ecule, 2,2′-oxybis(4-methylquinoline) (I) with formula C20H16ON2, which is reported herein.

Structural commentary

The geometry of (I) is fairly predictable, with all bond lengths and valence angles being in the expected range for organic compounds (Allen et al., 1987 ▸). The mol­ecule consists of two planar 4-methyl­quinoline aromatic moieties [the maximum deviations from the mean plane are 0.0104 (18) Å for C1 in the N1,C1–C9 moiety and 0.016 (2) Å for C13 in the N2,C11–C19 unit], almost perpendicular to each other [dihedral angle = 89.5 (2)°] and bound by an oxygen atom which forms an ether link (Fig. 1 ▸).
Figure 1

The mol­ecular structure and atom numbering of the title compound. Displacement ellipsoids for the non-H atoms are drawn at the 50% probability level.

Supra­molecular features

The crystal packing organization is essentially the result of two different types of π-stacking inter­actions involving inversion-related mol­ecules. Table 1 ▸ gives a survey of these π–π stacking inter­actions, in one case around (½, ½, ½) (Fig. 2 ▸) and in the other case around (0, 0, 0);(1, 1, 1) (Fig. 3 ▸). The overall effect of these inter­actions is the formation of chains parallel to [111] (Fig. 4 ▸). As expected from the lack of efficient hydrogen-bond donors, no significant hydrogen bonds linking the chains are present in the structure, as a result of which their mutual inter­action is rather weak.
Table 1

stacking interactions (, )

Cg1, Cg2, Cg3 and Cg4 are the centroids of the N1/C1C5, N2/C11C15, C4C9 and C14C19 rings, respectively. CgCg is the intercentroid distance, the dihedral angle is between the ring planes and mpd is the mean perpendicular distance between a centroid and the opposite plane.

  Cg Cg dihedral anglempd
Cg1Cg1i 3.7849(11)03.4446(7)
Cg1Cg3i 3.7775(11)0.83(8)3.4345(10)
Cg2Cg2ii 3.6036(11)03.4395(7)
Cg2Cg4ii 3.8817(12)0.73(10)3.4462(19)

Symmetry codes: (i) x, y, z; (ii) 1x, 1y, 1z.

Figure 2

Packing diagram showing one of the π–π inter­actions, stacked around (½, ½, ½).

Figure 3

Packing diagram showing the second type of π–π inter­action, stacked around (1, 1, 1).

Figure 4

The [111] chain resulting from the two types of π–π inter­actions.

Database survey

A systematic research in the Cambridge Structural Database (CSD; Version 5.35, update November 2014; Groom & Allen, 2014 ▸) using ConQuest (Bruno et al., (2002 ▸) revealed some structures fairly similar to (I), which are presented in Fig. 5 ▸ and identified by their CSD refcodes: MOSLAI (Hassan et al., 2009 ▸) and JUBRAZ (Liu et al., 1992 ▸), the main difference residing in the number and relative position of the nitro­gen atoms in the aromatic rings.
Figure 5

Two similar structures in the CSD [refcodes MOSLAI (Hassan et al., 2009 ▸) and JUBRAZ (Liu et al., 1992 ▸)].

Synthesis and crystallization

Prismatic colourless crystals of 2,2′-oxybis(4-methylquinoline) were grown from a 2 ml aqueous saturated solution of benserazide hydro­chloride (purchased from Sigma-Aldrich, Steinheim, Germany; purity level claimed > 98%) (9.3 mg) that was allowed to evaporate slowly at room temperature over 7 days. Several trials of slow evaporation of aqueous solutions under different temperature conditions (from 277 to 313 K) provided in all cases the same crystals, with the same unit-cell parameters. The main assumption is that the benserazide hydro­chloride has undergone a fundamental structure transformation during the aqueous recrystallization assays, but work is in progress to understand the mechanism, which does not seem to be obvious. Compound (I) could also be a by-product coming from a earlier step in the benserazide synthesis process (even if the qu­antity of crystalline material retrieved is relatively important). A calorimetric study has been undertaken on the crystalline material, and differential scanning calorimetry (DSC) provides an onset temperature (considered as the melting point) of 419.3 K, with no significant endo- or exothermic event before the fusion point. No spontaneous recrystallization occurs when the melt is allowed to cool down.

Refinement

Crystal data, data collection and structure refinement details are summarized in Table 2 ▸. The methyl H atoms were located from difference Fourier maps and their positions refined freely. All other H atoms were placed at idealized positions and allowed to ride on their parent atoms, with C—H distances of 0.93 Å and with U iso(H) = 1.2U eq(C).
Table 2

Experimental details

Crystal data
Chemical formulaC20H16N2O
M r 300.35
Crystal system, space groupTriclinic, P
Temperature (K)293
a, b, c ()7.8858(5), 7.9226(8), 13.0182(13)
, , ()104.267(9), 103.576(7), 91.967(7)
V (3)762.54(13)
Z 2
Radiation typeMo K
(mm1)0.08
Crystal size (mm)0.5 0.35 0.25
 
Data collection
DiffractometerOxford Diffraction Xcalibur (Ruby, Gemini) ultra
Absorption correctionMulti-scan (CrysAlis PRO; Oxford Diffraction, 2006)
T min, T max 0.960, 1.000
No. of measured, independent and observed [I > 2(I)] reflections3234, 2207, 1707
R int 0.024
(sin /)max (1)0.595
 
Refinement
R[F 2 > 2(F 2)], wR(F 2), S 0.046, 0.133, 1.03
No. of reflections2256
No. of parameters232
No. of restraints6
H-atom treatmentH atoms treated by a mixture of independent and constrained refinement
max, min (e 3)0.18, 0.14

Computer programs: CrysAlis PRO (Oxford Diffraction, 2006 ▸), SIR92 (Altomare et al., 1994 ▸), SHELXL97 (Sheldrick, 2015 ▸), ORTEPIII (Burnett Johnson, 1996 ▸), PLATON (Spek, 2009 ▸) and Mercury (Macrae et al., 2006 ▸).

Crystal structure: contains datablock(s) I, Global. DOI: 10.1107/S2056989015000717/bg2545sup1.cif Structure factors: contains datablock(s) I. DOI: 10.1107/S2056989015000717/bg2545Isup2.hkl Click here for additional data file. Supporting information file. DOI: 10.1107/S2056989015000717/bg2545Isup3.cml CCDC reference: 1034614 Additional supporting information: crystallographic information; 3D view; checkCIF report
C20H16N2OZ = 2
Mr = 300.35F(000) = 316
Triclinic, P1Dx = 1.308 Mg m3
Hall symbol: -P 1Mo Kα radiation, λ = 0.71073 Å
a = 7.8858 (5) ÅCell parameters from 1411 reflections
b = 7.9226 (8) Åθ = 3.7–28.7°
c = 13.0182 (13) ŵ = 0.08 mm1
α = 104.267 (9)°T = 293 K
β = 103.576 (7)°Prism, colourless
γ = 91.967 (7)°0.5 × 0.35 × 0.25 mm
V = 762.54 (13) Å3
Oxford Diffraction Xcalibur (Ruby, Gemini) ultra diffractometer2207 independent reflections
Radiation source: fine-focus sealed tube1707 reflections with I > 2σ(I)
Graphite monochromatorRint = 0.024
Detector resolution: 10.3712 pixels mm-1θmax = 25.0°, θmin = 3.5°
ω scansh = −7→9
Absorption correction: multi-scan (CrysAlis PRO; Oxford Diffraction, 2006)k = −9→5
Tmin = 0.960, Tmax = 1.000l = −14→15
3234 measured reflections
Refinement on F2Primary atom site location: structure-invariant direct methods
Least-squares matrix: fullSecondary atom site location: difference Fourier map
R[F2 > 2σ(F2)] = 0.046Hydrogen site location: inferred from neighbouring sites
wR(F2) = 0.133H atoms treated by a mixture of independent and constrained refinement
S = 1.03w = 1/[σ2(Fo2) + (0.0652P)2 + 0.0421P] where P = (Fo2 + 2Fc2)/3
2256 reflections(Δ/σ)max < 0.001
232 parametersΔρmax = 0.18 e Å3
6 restraintsΔρmin = −0.14 e Å3
0 constraints
Experimental. Absorption correction: CrysAlis PRO, Empirical absorption correction using spherical harmonics, implemented in SCALE3 ABSPACK scaling algorithm.
Geometry. All e.s.d.'s (except the e.s.d. in the dihedral angle between two l.s. planes) are estimated using the full covariance matrix. The cell e.s.d.'s are taken into account individually in the estimation of e.s.d.'s in distances, angles and torsion angles; correlations between e.s.d.'s in cell parameters are only used when they are defined by crystal symmetry. An approximate (isotropic) treatment of cell e.s.d.'s is used for estimating e.s.d.'s involving l.s. planes.
Refinement. Refinement of F2 against ALL reflections. The weighted R-factor wR and goodness of fit S are based on F2, conventional R-factors R are based on F, with F set to zero for negative F2. The threshold expression of F2 > σ(F2) is used only for calculating R-factors(gt) etc. and is not relevant to the choice of reflections for refinement. R-factors based on F2 are statistically about twice as large as those based on F, and R- factors based on ALL data will be even larger.
xyzUiso*/Ueq
O10.13084 (17)0.38253 (18)0.26211 (12)0.0696 (5)
N1−0.01449 (17)0.1056 (2)0.20704 (12)0.0470 (4)
N20.38771 (19)0.2735 (2)0.32211 (12)0.0530 (4)
C10.0147 (2)0.2537 (2)0.18566 (15)0.0482 (5)
C2−0.0638 (2)0.2993 (3)0.08862 (16)0.0507 (5)
C3−0.1801 (2)0.1811 (3)0.00729 (15)0.0458 (5)
C4−0.2184 (2)0.0150 (2)0.02535 (13)0.0415 (4)
C5−0.1336 (2)−0.0165 (2)0.12652 (14)0.0413 (4)
C6−0.3353 (2)−0.1194 (3)−0.05297 (16)0.0535 (5)
C7−0.3664 (2)−0.2761 (3)−0.03220 (18)0.0626 (6)
C8−0.2839 (2)−0.3060 (3)0.06810 (18)0.0599 (6)
C9−0.1692 (2)−0.1786 (3)0.14565 (16)0.0528 (5)
C10−0.2614 (3)0.2203 (4)−0.09923 (19)0.0620 (6)
C110.2483 (2)0.3332 (2)0.34593 (15)0.0506 (5)
C120.2112 (2)0.3641 (3)0.44746 (18)0.0560 (5)
C130.3299 (3)0.3308 (2)0.53294 (16)0.0535 (5)
C140.4866 (2)0.2617 (2)0.51214 (15)0.0479 (5)
C150.5100 (2)0.2357 (2)0.40549 (15)0.0472 (5)
C160.6200 (3)0.2177 (3)0.59128 (18)0.0655 (6)
C170.7657 (3)0.1528 (3)0.5655 (2)0.0808 (8)
C180.7892 (3)0.1314 (3)0.4606 (2)0.0797 (7)
C190.6640 (3)0.1713 (3)0.38176 (19)0.0644 (6)
C200.2972 (4)0.3663 (4)0.6447 (2)0.0863 (8)
H2−0.03600.40950.08040.061*
H6−0.3920−0.1009−0.11990.064*
H7−0.4432−0.3639−0.08520.075*
H8−0.3071−0.41280.08210.072*
H9−0.1140−0.19980.21200.063*
H10A−0.386 (3)0.211 (3)−0.1129 (17)0.070 (6)*
H10B−0.229 (3)0.137 (3)−0.159 (2)0.081 (7)*
H10C−0.219 (3)0.337 (4)−0.100 (2)0.096 (8)*
H120.10620.40720.45720.067*
H160.60780.23340.66230.079*
H170.85110.12220.61860.097*
H180.89120.08950.44460.096*
H190.68010.15600.31160.077*
H20A0.186 (2)0.408 (3)0.648 (3)0.137 (12)*
H20B0.306 (3)0.259 (3)0.669 (3)0.140 (12)*
H20C0.389 (3)0.451 (3)0.698 (2)0.129 (11)*
U11U22U33U12U13U23
O10.0706 (9)0.0484 (9)0.0657 (10)−0.0002 (6)−0.0204 (7)0.0072 (7)
N10.0449 (9)0.0537 (10)0.0366 (9)0.0033 (7)0.0035 (6)0.0079 (8)
N20.0590 (11)0.0537 (10)0.0368 (9)0.0031 (8)0.0042 (7)0.0023 (8)
C10.0407 (10)0.0487 (11)0.0465 (12)0.0059 (8)0.0027 (8)0.0042 (10)
C20.0466 (11)0.0502 (11)0.0542 (12)0.0094 (8)0.0066 (9)0.0165 (10)
C30.0375 (10)0.0618 (12)0.0397 (10)0.0139 (8)0.0099 (7)0.0146 (10)
C40.0333 (10)0.0552 (11)0.0349 (10)0.0071 (7)0.0105 (7)0.0072 (9)
C50.0361 (10)0.0496 (11)0.0371 (10)0.0041 (7)0.0116 (7)0.0072 (9)
C60.0456 (11)0.0677 (14)0.0384 (11)0.0031 (9)0.0054 (8)0.0030 (10)
C70.0480 (12)0.0649 (14)0.0609 (14)−0.0080 (9)0.0089 (9)−0.0032 (12)
C80.0537 (13)0.0568 (13)0.0692 (15)−0.0040 (9)0.0203 (10)0.0128 (12)
C90.0479 (11)0.0644 (13)0.0487 (12)0.0016 (9)0.0140 (8)0.0182 (11)
C100.0562 (15)0.0813 (18)0.0507 (14)0.0172 (12)0.0076 (10)0.0254 (13)
C110.0506 (12)0.0446 (11)0.0432 (12)−0.0029 (8)−0.0034 (9)0.0026 (9)
C120.0456 (11)0.0517 (12)0.0681 (14)−0.0010 (8)0.0162 (9)0.0099 (11)
C130.0682 (13)0.0445 (11)0.0459 (12)−0.0100 (9)0.0213 (9)0.0035 (9)
C140.0535 (12)0.0425 (11)0.0406 (11)−0.0094 (8)0.0038 (8)0.0074 (9)
C150.0476 (11)0.0448 (11)0.0422 (11)−0.0021 (8)0.0064 (8)0.0042 (9)
C160.0767 (15)0.0604 (13)0.0480 (13)−0.0077 (11)−0.0051 (10)0.0151 (11)
C170.0659 (16)0.0710 (16)0.086 (2)−0.0015 (12)−0.0221 (13)0.0247 (15)
C180.0536 (14)0.0674 (16)0.108 (2)0.0078 (10)0.0065 (13)0.0165 (15)
C190.0631 (14)0.0631 (14)0.0649 (14)0.0069 (10)0.0185 (10)0.0107 (11)
C200.118 (2)0.087 (2)0.0657 (18)0.0003 (17)0.0483 (16)0.0180 (16)
O1—C11.371 (2)C10—H10C0.97 (3)
O1—C111.401 (2)C10—H10A0.95 (2)
N1—C11.296 (2)C10—H10B0.97 (3)
N1—C51.376 (2)C11—C121.386 (3)
N2—C111.285 (2)C12—H120.9300
N2—C151.373 (2)C13—C121.363 (3)
C2—C31.355 (3)C13—C201.497 (3)
C2—C11.408 (2)C14—C161.408 (3)
C2—H20.9300C14—C151.409 (3)
C3—C101.496 (3)C14—C131.426 (3)
C4—C61.407 (3)C15—C191.404 (3)
C4—C31.427 (3)C16—C171.354 (3)
C5—C91.398 (2)C16—H160.9300
C5—C41.416 (2)C17—H170.9300
C6—C71.360 (3)C18—C171.391 (4)
C6—H60.9300C18—H180.9300
C7—H70.9300C19—C181.354 (3)
C8—C71.396 (3)C19—H190.9300
C8—H80.9300C20—H20A0.956 (18)
C9—C81.365 (3)C20—H20B0.981 (18)
C9—H90.9300C20—H20C0.978 (19)
O1—C1—C2114.47 (16)C9—C8—H8119.9
N1—C1—O1119.50 (16)C11—N2—C15116.43 (16)
N1—C1—C2126.03 (17)C11—C12—H12120.3
N1—C5—C9118.13 (16)C12—C11—O1118.03 (18)
N1—C5—C4122.58 (15)C12—C13—C14117.55 (18)
N2—C11—C12126.19 (17)C12—C13—C20121.2 (2)
N2—C11—O1115.61 (18)C13—C12—C11119.38 (18)
N2—C15—C19117.56 (18)C13—C12—H12120.3
N2—C15—C14122.48 (17)C13—C20—H20A113.8 (19)
C1—O1—C11117.49 (14)C13—C20—H20B109 (2)
C1—N1—C5116.00 (15)C13—C20—H20C111.1 (18)
C1—C2—H2120.3C14—C13—C20121.2 (2)
C2—C3—C4117.60 (16)C14—C16—H16119.5
C2—C3—C10121.44 (19)C15—C14—C13117.96 (16)
C3—C2—C1119.35 (17)C15—C19—H19119.9
C3—C2—H2120.3C16—C14—C15117.77 (19)
C3—C10—H10A110.7 (12)C16—C14—C13124.27 (19)
C3—C10—H10B109.6 (13)C16—C17—C18120.8 (2)
C3—C10—H10C111.3 (14)C16—C17—H17119.6
C4—C3—C10120.92 (19)C17—C16—C14121.0 (2)
C4—C6—H6119.5C17—C16—H16119.5
C5—C4—C3118.42 (17)C17—C18—H18119.9
C5—C9—H9119.6C18—C17—H17119.6
C6—C4—C5118.45 (17)C18—C19—C15120.2 (2)
C6—C4—C3123.13 (16)C18—C19—H19119.9
C6—C7—C8120.43 (19)C19—C15—C14119.95 (17)
C6—C7—H7119.8C19—C18—C17120.3 (2)
C7—C6—C4120.92 (18)C19—C18—H18119.9
C7—C6—H6119.5H10A—C10—H10B108.5 (18)
C7—C8—H8119.9H10C—C10—H10A109.4 (17)
C8—C7—H7119.8H10C—C10—H10B107 (2)
C8—C9—C5120.81 (18)H20A—C20—H20B109.3 (18)
C8—C9—H9119.6H20A—C20—H20C108.4 (19)
C9—C5—C4119.28 (17)H20B—C20—H20C104.8 (17)
C9—C8—C7120.11 (18)
O1—C11—C12—C13−174.70 (15)C9—C5—C4—C3−179.86 (14)
N1—C5—C4—C6178.55 (15)C9—C8—C7—C6−0.9 (3)
N1—C5—C4—C3−0.9 (3)C11—O1—C1—N117.5 (3)
N1—C5—C9—C8−178.88 (17)C11—O1—C1—C2−162.77 (16)
N2—C15—C19—C18−179.87 (19)C11—N2—C15—C19−179.60 (17)
C1—O1—C11—N283.6 (2)C11—N2—C15—C14−0.5 (3)
C1—O1—C11—C12−100.8 (2)C13—C14—C15—C19178.68 (16)
C1—N1—C5—C9179.85 (15)C13—C14—C15—N2−0.4 (3)
C1—N1—C5—C40.9 (3)C13—C14—C16—C17−179.87 (19)
C1—C2—C3—C40.6 (3)C14—C13—C12—C11−1.2 (3)
C1—C2—C3—C10−177.41 (18)C14—C15—C19—C181.0 (3)
C3—C2—C1—N1−0.7 (3)C14—C16—C17—C181.4 (3)
C3—C2—C1—O1179.64 (16)C15—N2—C11—C120.6 (3)
C3—C4—C6—C7179.46 (16)C15—N2—C11—O1175.70 (14)
C4—C5—C9—C80.1 (3)C15—C14—C13—C121.2 (2)
C4—C6—C7—C80.6 (3)C15—C14—C13—C20−178.48 (19)
C5—C4—C3—C10178.14 (17)C15—C14—C16—C170.1 (3)
C5—N1—C1—O1179.57 (16)C15—C19—C18—C170.4 (3)
C5—N1—C1—C2−0.1 (3)C16—C14—C15—N2179.68 (16)
C5—C4—C3—C20.1 (3)C16—C14—C15—C19−1.3 (3)
C5—C4—C6—C70.0 (3)C16—C14—C13—C12−178.83 (17)
C5—C9—C8—C70.5 (3)C16—C14—C13—C201.4 (3)
C6—C4—C3—C2−179.31 (16)C19—C18—C17—C16−1.6 (4)
C6—C4—C3—C10−1.3 (3)C20—C13—C12—C11178.5 (2)
C9—C5—C4—C6−0.4 (3)
  9 in total

1.  New software for searching the Cambridge Structural Database and visualizing crystal structures.

Authors:  Ian J Bruno; Jason C Cole; Paul R Edgington; Magnus Kessler; Clare F Macrae; Patrick McCabe; Jonathan Pearson; Robin Taylor
Journal:  Acta Crystallogr B       Date:  2002-05-29

Review 2.  Parkinson's disease.

Authors:  Ali Samii; John G Nutt; Bruce R Ransom
Journal:  Lancet       Date:  2004-05-29       Impact factor: 79.321

3.  The Cambridge Structural Database in retrospect and prospect.

Authors:  Colin R Groom; Frank H Allen
Journal:  Angew Chem Int Ed Engl       Date:  2014-01-02       Impact factor: 15.336

4.  [Our experience in the treatment of Parkinson's disease with L-dopa plus RO 4-4602 combination].

Authors:  G Campanella; R Pennetta
Journal:  Acta Neurol (Napoli)       Date:  1974 May-Jun

5.  Glial activation is associated with l-DOPA induced dyskinesia and blocked by a nitric oxide synthase inhibitor in a rat model of Parkinson's disease.

Authors:  Mariza Bortolanza; Roberta Cavalcanti-Kiwiatkoski; Fernando E Padovan-Neto; Célia Aparecida da-Silva; Miso Mitkovski; Rita Raisman-Vozari; Elaine Del-Bel
Journal:  Neurobiol Dis       Date:  2014-10-30       Impact factor: 5.996

6.  Blood-brain barrier to carbidopa (MK-486) and Ro 4-4602, peripheral dopa decarboxylase inhibitors.

Authors:  W G Clark; W H Oldendorf; W G Dewherst
Journal:  J Pharm Pharmacol       Date:  1973-05       Impact factor: 3.765

7.  2-Naphthyl quinoxalin-2-yl ether.

Authors:  Noor Doha Hassan; Hairul Anuar Tajuddin; Zanariah Abdullah; Seik Weng Ng
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2009-03-11

8.  Crystal structure refinement with SHELXL.

Authors:  George M Sheldrick
Journal:  Acta Crystallogr C Struct Chem       Date:  2015-01-01       Impact factor: 1.172

9.  Structure validation in chemical crystallography.

Authors:  Anthony L Spek
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2009-01-20
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.